In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery

Jian Zhang(Chinese Center For Disease Control and Prevention), Fuchu He(Beijing University of Technology), Longqin Sun(Beijing Proteome Research Center), Wei Liu(Arizona State University), Ning Chen(Canadian Light Source (Canada)), Baocai Xing(Ministry of Education), Miantao Wu(Sun Yat-sen University), Wei Sun(Beijing Proteome Research Center), Hao Ning(The Affiliated Yongchuan Hospital of Chongqing Medical University), Min Lu(South China Agricultural University), Xiaohang Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College)
British Journal of Cancer
October 12, 2017
10.1038/bjc.2017.344
Cited by 51

Related Papers

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database
|PROTEOMICS|2005|792
Integrative Proteomic Characterization of Human Lung Adenocarcinoma
|Cell|2020|634
Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression
|Developmental Cell|2014|389
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy
|Nature Medicine|2015|355